Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pozen MT 100 Benefit In Migraine Does Not Outweigh Tardive Dyskinesia Risk

Aug 04 2005

• By Danielle Foullon and Chris Hollis

Related Content

Pozen MT 100 Indication For Migraine Without Nausea To Be Considered By Committee

Aug 03 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window